SecBot SecBot

AAVXF

Abivax S.A.
OTC· Pharmaceutical Preparations· Inc. I0· CIK 0001956827 Biotech & Drug Discovery
$139.00 +0.00 (+0.00%)
Oct 23 4:00 PM ET · prev $139.00
1 year
+57.0%
from $88.55 · Oct 24
30 days
0.0%
from $139.00
52-week range
$71.26–139.00
0% from high · low Jun 2
Avg volume 20D
0
Sep 28 spike 0
Short interest
704.6K
+15.0%
Filing reports
3
analyzed by SecBot
SecBot read MIXED 3 reports · latest
Balance 0 bearish · 0 bullish · 3 neutral oldest → newest, height = score
Avg score ·High conf. 3/3
Strongest NEUTRAL Abivax reported Q1 2026 financial results with a net loss of €48.5 million, improved from a €52.4 million…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

  • X Jul 15 Short interest jumps 357.4% to 135.0K
  • X Aug 14 Short interest jumps 154.7% to 355.0K
  • X Aug 31 Short interest jumps 36.4% to 484.1K
  • X Sep 15 Short interest jumps 26.6% to 612.9K

Signal stack

Where each data set points today.

  • Short sellersSTEADY

    Short interest +15.0% to 704.6K shares.

  • TrendRANGE

    0% above its 50-day average. New closing high $139.00 on Oct 23.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
May 22, 2026 SEC
Abivax reported Q1 2026 financial results with a net loss of €48.5 million, improved from a €52.4 million loss in Q1…
6-K — Impact 5/10
May 20, 2026 SEC
Abivax S.A. reported the results of its May 11, 2026 annual general meeting, where all 33 resolutions proposed by the…
6-K — Impact 2/10
Apr 20, 2026 SEC
Abivax S.A. filed a 6-K to announce the availability of preparatory documents for its Annual Ordinary and…
6-K — Impact 2/10

Earnings setup

Estimates

Revision history: 🔒 Fresh data — subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data — subscribers only
Next Q🔒 Fresh data — subscribers only
Current FY🔒 Fresh data — subscribers only
Next FY🔒 Fresh data — subscribers only

Short side

FINRA· Sep 30, 2026
704,635
shares short
+15.0%
vs prior settlement

SecBot reports

3 filings · 0 bullish · 0 bearish · 3 neutral
All AAVXF filing & press-release reports (3)